Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
05 2019
Historique:
received: 28 11 2017
accepted: 02 04 2019
pubmed: 3 5 2019
medline: 18 12 2019
entrez: 3 5 2019
Statut: ppublish

Résumé

The perpetuation of inflammation is an important pathophysiological contributor to the global medical burden. Chronic inflammation is promoted by non-programmed cell death

Identifiants

pubmed: 31043745
doi: 10.1038/s41586-019-1167-6
pii: 10.1038/s41586-019-1167-6
pmc: PMC6716525
mid: NIHMS1046629
doi:

Substances chimiques

Histones 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-240

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM008042
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI125429
Pays : United States
Organisme : NIH HHS
ID : R56AI125429-01A1
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008185
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR071307
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Kolb, J. P., Oguin, T. H., III, Oberst, A. & Martinez, J. Programmed cell death and inflammation: winter is coming. Trends Immunol. 38, 705–718 (2017).
doi: 10.1016/j.it.2017.06.009
Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36–46 (2010).
doi: 10.1038/nri2675
Clarke, M. C. H. et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat. Med. 12, 1075–1080 (2006).
doi: 10.1038/nm1459
Hartwig, H. et al. Atherosclerotic plaque destabilization in mice: a comparative study. PLoS ONE 10, e0141019 (2015).
doi: 10.1371/journal.pone.0141019
Silvestre-Roig, C. et al. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ. Res. 114, 214–226 (2014).
doi: 10.1161/CIRCRESAHA.114.302355
Bennett, M. R., Sinha, S. & Owens, G. K. Vascular smooth muscle cells in atherosclerosis. Circ. Res. 118, 692–702 (2016).
doi: 10.1161/CIRCRESAHA.115.306361
Rossaint, J. et al. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood 123, 2573–2584 (2014).
doi: 10.1182/blood-2013-07-516484
Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134–147 (2018).
doi: 10.1038/nri.2017.105
Kumar, S. V. et al. Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN. J. Am. Soc. Nephrol. 26, 2399–2413 (2015).
doi: 10.1681/ASN.2014070673
Tagai, C., Morita, S., Shiraishi, T., Miyaji, K. & Iwamuro, S. Antimicrobial properties of arginine- and lysine-rich histones and involvement of bacterial outer membrane protease T in their differential mode of actions. Peptides 32, 2003–2009 (2011).
doi: 10.1016/j.peptides.2011.09.005
Lee, E. Y., Fulan, B. M., Wong, G. C. & Ferguson, A. L. Mapping membrane activity in undiscovered peptide sequence space using machine learning. Proc. Natl Acad. Sci. USA 113, 13588–13593 (2016).
doi: 10.1073/pnas.1609893113
Schmidt, N. W. et al. Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J. Am. Chem. Soc. 133, 6720–6727 (2011).
doi: 10.1021/ja200079a
Schmidt, N. W. & Wong, G. C. Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering. Curr. Opin. Solid State Mater. Sci. 17, 151–163 (2013).
doi: 10.1016/j.cossms.2013.09.004
Franck, G. et al. Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion. Circ. Res. 123, 33–42 (2018).
doi: 10.1161/CIRCRESAHA.117.312494
Saffarzadeh, M. et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 7, e32366 (2012).
doi: 10.1371/journal.pone.0032366
Xu, J. et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15, 1318–1321 (2009).
doi: 10.1038/nm.2053
Menegazzi, R., Decleva, E. & Dri, P. Killing by neutrophil extracellular traps: fact or folklore? Blood 119, 1214–1216 (2012).
doi: 10.1182/blood-2011-07-364604
Hasenberg, A. et al. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat. Methods 12, 445–452 (2015).
doi: 10.1038/nmeth.3322
Dzhagalov, I., St John, A. & He, Y. W. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 109, 1620–1626 (2007).
doi: 10.1182/blood-2006-03-013771
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A. & Schwartz, S. M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262–1275 (2000).
doi: 10.1161/01.ATV.20.5.1262
Gorelik, R. & Gautreau, A. Quantitative and unbiased analysis of directional persistence in cell migration. Nat. Protoc. 9, 1931–1943 (2014).
doi: 10.1038/nprot.2014.131
Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405–413 (2016).
doi: 10.1021/acs.jctc.5b00935
Wichapong, K. et al. Structure-based design of peptidic inhibitors of the interaction between CC chemokine ligand 5 (CCL5) and human neutrophil peptides 1 (HNP1). J. Med. Chem. 59, 4289–4301 (2016).
doi: 10.1021/acs.jmedchem.5b01952
van Zundert, G. C. P. et al. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 428, 720–725 (2016).
doi: 10.1016/j.jmb.2015.09.014
Alard, J. E. et al. Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5. Sci. Transl. Med. 7, 317ra196 (2015).
doi: 10.1126/scitranslmed.aad5330
Lee, E. Y., Lee, M. W., Fulan, B. M., Ferguson, A. L. & Wong, G. C. L. What can machine learning do for antimicrobial peptides, and what can antimicrobial peptides do for machine learning? Interface Focus 7, 20160153 (2017).
doi: 10.1098/rsfs.2016.0153
Lee, E. Y., Wong, G. C. L. & Ferguson, A. L. Machine learning-enabled discovery and design of membrane-active peptides. Bioorg. Med. Chem. 26, 2708–2718 (2018).
doi: 10.1016/j.bmc.2017.07.012
McGuffin, L. J., Bryson, K. & Jones, D. T. The PSIPRED protein structure prediction server. Bioinformatics 16, 404–405 (2000).
doi: 10.1093/bioinformatics/16.4.404
Schmidt, N. W., Mishra, A., Wang, J., DeGrado, W. F. & Wong, G. C. Influenza virus A M2 protein generates negative Gaussian membrane curvature necessary for budding and scission. J. Am. Chem. Soc. 135, 13710–13719 (2013).
doi: 10.1021/ja400146z
Ilavsky, J. Nika: software for two-dimensional data reduction. J. Appl. Crystallogr. 45, 324–328 (2012).
doi: 10.1107/S0021889812004037
Hammersley, A. P. FIT2D: a multi-purpose data reduction, analysis and visualization program. J. Appl. Crystallogr. 49, 646–652 (2016).
doi: 10.1107/S1600576716000455
Necas, D. & Klapetek, P. Gwyddion: an open-source software for SPM data analysis. Cent. Eur. J. Phys. 10, 181–188 (2012).
Chen, S. W. & Pellequer, J. L. DeStripe: frequency-based algorithm for removing stripe noises from AFM images. BMC Struct. Biol. 11, 7 (2011).
doi: 10.1186/1472-6807-11-7
Korchev, Y. E. et al. Specialized scanning ion-conductance microscope for imaging of living cells. J. Microsc. 188, 17–23 (1997).
doi: 10.1046/j.1365-2818.1997.2430801.x

Auteurs

Carlos Silvestre-Roig (C)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany. carlos.silvestre@med.uni-muenchen.de.
Department of Pathology, AMC, Amsterdam, The Netherlands. carlos.silvestre@med.uni-muenchen.de.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany. carlos.silvestre@med.uni-muenchen.de.

Quinte Braster (Q)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
Department of Pathology, AMC, Amsterdam, The Netherlands.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Kanin Wichapong (K)

Department of Biochemistry, CARIM, University Maastricht, Maastricht, The Netherlands.

Ernest Y Lee (EY)

Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.

Jean Marie Teulon (JM)

Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.

Nihel Berrebeh (N)

Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.

Janine Winter (J)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

José M Adrover (JM)

Area of Developmental and Cell Biology, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Giancarlo Santiago Santos (GS)

Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.

Alexander Froese (A)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Patricia Lemnitzer (P)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

Almudena Ortega-Gómez (A)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Raphael Chevre (R)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

Julian Marschner (J)

Medizinische Klinik und Poliklinik IV, LMU München, Munich, Germany.

Ariane Schumski (A)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Carla Winter (C)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Laura Perez-Olivares (L)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

Chang Pan (C)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

Nicole Paulin (N)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

Tom Schoufour (T)

Department of Pathology, AMC, Amsterdam, The Netherlands.

Helene Hartwig (H)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
Department of Pathology, AMC, Amsterdam, The Netherlands.

Silvia González-Ramos (S)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.

Frits Kamp (F)

BMC, Metabolic Biochemistry, LMU München, Munich, Germany.

Remco T A Megens (RTA)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
Department of Biomedical Engineering, CARIM, University Maastricht, Maastricht, The Netherlands.

Kerri A Mowen (KA)

The Scripps Research Institute, La Jolla, CA, USA.

Matthias Gunzer (M)

Institute for Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany.

Lars Maegdefessel (L)

German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Vascular and Endovascular Surgery, Technical University Munich, Munich, Germany.
Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.

Tilman Hackeng (T)

Department of Biochemistry, CARIM, University Maastricht, Maastricht, The Netherlands.

Esther Lutgens (E)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
Department of Medical Biochemistry, AMC, Amsterdam, The Netherlands.

Mat Daemen (M)

Department of Pathology, AMC, Amsterdam, The Netherlands.

Julia von Blume (J)

Max Planck Institute of Biochemistry, Martinsried, Germany.

Hans-Joachim Anders (HJ)

Medizinische Klinik und Poliklinik IV, LMU München, Munich, Germany.

Viacheslav O Nikolaev (VO)

Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Jean-Luc Pellequer (JL)

Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.

Christian Weber (C)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
Department of Biochemistry, CARIM, University Maastricht, Maastricht, The Netherlands.

Andrés Hidalgo (A)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany.
Area of Developmental and Cell Biology, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

Gerry A F Nicolaes (GAF)

Department of Biochemistry, CARIM, University Maastricht, Maastricht, The Netherlands.

Gerard C L Wong (GCL)

Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.

Oliver Soehnlein (O)

Institute for Cardiovascular Prevention (IPEK), LMU München, Munich, Germany. oliver.soehnlein@gmail.com.
Department of Pathology, AMC, Amsterdam, The Netherlands. oliver.soehnlein@gmail.com.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany. oliver.soehnlein@gmail.com.
Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. oliver.soehnlein@gmail.com.
Department of Physiology and Pharmacology (FyFa), Karolinska Institutet, Stockholm, Sweden. oliver.soehnlein@gmail.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH